Search the Appendices of Resolution CM/Res(2018)1
2416 found
| INN | ATC Code | Country | Classification | Last update | MA Number ▼ | Registration date | Status | |
|---|---|---|---|---|---|---|---|---|
| UBLITUXIMAB | L04AG14 | IT | I | 14-11-2023 | EMEA/H/C/005914 | 31-05-2023 | VALID | |
| QUIZARTINIB | L01EX11 | IT | I | 13-05-2024 | EMEA/H/C/005910 | 06-11-2023 | VALID | |
| ELRANATAMAB | L01FX32 | IT | I | 13-05-2024 | EMEA/H/C/005908 | 07-12-2023 | VALID | |
| REZAFUNGIN | J02AX08 | IT | I | 13-05-2024 | EMEA/H/C/005900 | 22-12-2023 | VALID | |
| LEBRIKIZUMAB | D11AH10 | IT | I | 13-05-2024 | EMEA/H/C/005894 | 16-11-2023 | VALID | |
| SPESOLIMAB | L04AC22 | IT | I | 18-08-2023 | EMEA/H/C/005874 | 09-12-2022 | VALID | |
| ATOGEPANT | N02CD07 | IT | I | 14-11-2023 | EMEA/H/C/005871 | 11-08-2023 | VALID | |
| ZOLBETUXIMAB | L01FX31 | IT | POM | 01-08-2025 | EMEA/H/C/005868 | 19-09-2024 | VALID | |
| TALQUETAMAB | L01FX29 | IT | I | 14-11-2023 | EMEA/H/C/005864 | 21-08-2023 | VALID | |
| MARALIXIBAT CHLORIDE | A05AX04 | IT | I | 18-08-2023 | EMEA/H/C/005857 | 09-12-2022 | VALID | |
| REGDANVIMAB | J06BD06 | IT | I | 28-04-2022 | EMEA/H/C/005854 | 12-11-2021 | VALID | |
| VUTRISIRAN | N07XX18 | IT | I | 18-11-2022 | EMEA/H/C/005852 | 15-09-2022 | VALID | |
| FEZOLINETANT | G02CX06 | IT | I | 13-05-2024 | EMEA/H/C/005851 | 07-12-2023 | VALID | |
| EFGARTIGIMOD ALFA | L04AA58 | IT | I | 18-11-2022 | EMEA/H/C/005849 | 10-08-2022 | VALID | |
| RUXOLITINIB | D11AH09 | IT | I | 18-08-2023 | EMEA/H/C/005843 | 19-04-2023 | VALID | |
| ROZANOLIXIZUMAB | L04AG16 | IT | I | 13-05-2024 | EMEA/H/C/005824 | 05-01-2024 | VALID | |
| INEBILIZUMAB | L04AG10 | IT | I | 18-11-2022 | EMEA/H/C/005818 | 25-04-2022 | VALID | |
| CASIRIVIMAB AND IMDEVIMAB | J06BD07 | IT | I | 28-04-2022 | EMEA/H/C/005814 | 12-11-2021 | VALID | |
| TIXAGEVIMAB AND CILGAVIMAB | J06BD03 | IT | I | 18-11-2022 | EMEA/H/C/005788 | 25-03-2022 | VALID | |
| MARIBAVIR | J05AX10 | IT | I | 18-08-2023 | EMEA/H/C/005787 | 09-11-2022 | VALID | |
| SPARSENTAN | C09XX01 | IT | POM | 01-08-2025 | EMEA/H/C/005783 | 19-04-2024 | VALID | |
| SUTIMLIMAB | L04AJ04 | IT | I | 18-08-2023 | EMEA/H/C/005776 | 15-11-2022 | VALID | |
| TRASTUZUMAB | L01XC03 | IT | I | 13-05-2024 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
| MOMELOTINIB | L01EJ04 | IT | I | 13-05-2024 | EMEA/H/C/005768 | 25-01-2024 | VALID | |
| IPTACOPAN | L04AJ08 | IT | POM | 01-08-2025 | EMEA/H/C/005764 | 17-05-2024 | VALID | |
| EXAGAMGLOGENE AUTOTEMCEL | B06AX05 | IT | I | 13-05-2024 | EMEA/H/C/005763 | 09-02-2024 | VALID | |
| DEUCRAVACITINIB | L04AF07 | IT | I | 18-08-2023 | EMEA/H/C/005755 | 24-03-2023 | VALID | |
| GLOFITAMAB | L01FX28 | IT | I | 14-11-2023 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
| COVID-19 VACCINES | J07BX03 | IT | I | 03-03-2021 | EMEA/H/C/005735 | 21-12-2020 | VALID | |
| RIMEGEPANT | N02CD06 | IT | I | 18-11-2022 | EMEA/H/C/005725 | 25-04-2022 | VALID | |
| BEVACIZUMAB | S01LA08 | IT | POM | 01-08-2025 | EMEA/H/C/005723 | 27-05-2024 | VALID | |
| LONCASTUXIMAB TESIRINE | L01FX22 | IT | I | 18-08-2023 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
| MELPHALAN FLUFENAMIDE | L01AA10 | IT | I | 18-11-2022 | EMEA/H/C/005681 | 17-08-2022 | VALID | |
| VAMOROLONE | H02AB18 | IT | I | 13-05-2024 | EMEA/H/C/005679 | 14-12-2023 | VALID | |
| SOTROVIMAB | J06BD05 | IT | I | 28-04-2022 | EMEA/H/C/005676 | 17-12-2021 | VALID | |
| SOTATERCEPT | C02KC06 | IT | POM | 01-08-2025 | EMEA/H/C/005647 | 22-08-2024 | VALID | |
| FARICIMAB | S01LA09 | IT | I | 18-11-2022 | EMEA/H/C/005642 | 15-09-2022 | VALID | |
| LENACAPAVIR | J05AX31 | IT | I | 18-11-2022 | EMEA/H/C/005638 | 17-08-2022 | VALID | |
| SOMATROGON | H01AC08 | IT | I | 28-04-2022 | EMEA/H/C/005633 | 14-02-2022 | VALID | |
| FUTIBATINIB | L01EN04 | IT | I | 14-11-2023 | EMEA/H/C/005627 | 04-07-2023 | VALID | |
| PEGUNIGALSIDASE ALFA | A16AB20 | IT | I | 14-11-2023 | EMEA/H/C/005618 | 04-05-2023 | VALID | |
| RIPRETINIB | L01EX19 | IT | I | 28-04-2022 | EMEA/H/C/005614 | 18-11-2021 | VALID | |
| DIFELIKEFALIN | V03AX04 | IT | I | 18-11-2022 | EMEA/H/C/005612 | 25-04-2022 | VALID | |
| ASCIMINIB | L01EA06 | IT | I | 18-11-2022 | EMEA/H/C/005605 | 25-08-2022 | VALID | |
| TEZEPELUMAB | R03DX11 | IT | I | 18-11-2022 | EMEA/H/C/005588 | 19-09-2022 | VALID | |
| PEGCETACOPLAN | L04AJ03 | IT | I | 28-04-2022 | EMEA/H/C/005553 | 13-12-2021 | VALID | |
| ARTESUNATE | P01BE03 | IT | I | 28-04-2022 | EMEA/H/C/005550 | 22-11-2021 | VALID | |
| MITAPIVAT | B06AX04 | IT | I | 18-08-2023 | EMEA/H/C/005540 | 09-11-2022 | VALID | |
| AVACOPAN | L04AJ05 | IT | I | 28-04-2022 | EMEA/H/C/005523 | 11-01-2022 | VALID | |
| PIFLUFOLASTAT (18F) | V09IX16 | IT | I | 14-11-2023 | EMEA/H/C/005520 | 24-07-2023 | VALID |